换一批
换一批Safety and efficacy of high-dose cyclophosphamide, etoposide and ranimustine regimen followed by autologous peripheral blood stem cell transplant for patients with diffuse large B-cell lymphoma.
作者：
主题词
成年人(Adult);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);综合疗法(Combined Modality Therapy);环磷酰胺(Cyclophosphamide);疾病恶化(Disease Progression);无病生存(Disease-Free Survival);剂量效应关系, 药物(Dose-Response Relationship, Drug);依托泊甙(Etoposide);女(雌)性(Female);人类(Humans);Kaplan-Meiers评估(Kaplan-Meier Estimate);淋巴瘤, 大B细胞, 弥漫性(Lymphoma, Large B-Cell, Diffuse);男(雄)性(Male);中年人(Middle Aged);肿瘤复发, 局部(Neoplasm Recurrence, Local);亚硝基脲化合物(Nitrosourea Compounds);外周血干细胞移植(Peripheral Blood Stem Cell Transplantation);回顾性研究(Retrospective Studies);移植预处理(Transplantation Conditioning);移植, 自体(Transplantation, Autologous);治疗结果(Treatment Outcome);青年人(Young Adult)
DOI
10.3109/10428194.2014.889827
PMID
24491027
发布时间
2019-01-16
- 浏览64
Leukemia & lymphoma
2514-9页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
